We are live on ! Find out more
PC

Pier Capital Portfolio holdings

AUM $755M
1-Year Est. Return 94.38%
This Fund
S&P 500
This Quarter Est. Return
+13.14%
1 Year Est. Return
+94.38%
3 Year Est. Return
+222.94%
5 Year Est. Return
+261.19%
10 Year Est. Return
+2,769.67%
AUM
$727M
AUM Growth
+$27.6M
Cap. Flow
-$18.9M
Cap. Flow %
-2.6%
Top 10 Hldgs %
17.01%
Holding
132
New
15
Increased
61
Reduced
38
Closed
6

Top Buys

Rank Stock Value
1
CAMT icon
Camtek
CAMT
+$8.89M
2
FORM icon
FormFactor
FORM
+$8.4M
3
VRNS icon
Varonis Systems
VRNS
+$8.17M
4
RPD icon
Rapid7
RPD
+$8M
5
MNDY icon
monday.com
MNDY
+$5.88M

Sector Composition

Rank Sector Weight
1 Technology 29.75%
2 Healthcare 21.91%
3 Industrials 17.38%
4 Consumer Discretionary 13.53%
5 Consumer Staples 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGNY icon
76
Progyny
PGNY
$1.99B
$4.56M 0.63%
119,540
-549
-0.5% -$20.8K
MRVI icon
77
Maravai LifeSciences
MRVI
$861M
$4.39M 0.6%
506,295
+219,446
+77% +$1.48M
CLS icon
78
Celestica
CLS
$43.8B
$4.38M 0.6%
+97,526
New +$3.7M
GO icon
79
Grocery Outlet
GO
$1.07B
$4.37M 0.6%
151,679
-89,804
-37% -$2.37M
SITM icon
80
SiTime
SITM
$20.7B
$4.3M 0.59%
46,080
+7,566
+20% +$796K
INMD icon
81
InMode
INMD
$876M
$4.29M 0.59%
198,289
-1,559
-0.8% -$34.9K
GPCR icon
82
Structure Therapeutics
GPCR
$3.83B
$4.18M 0.58%
97,557
+61,904
+174% +$2.61M
SITE icon
83
SiteOne Landscape Supply
SITE
$4.22B
$4.06M 0.56%
23,235
-305
-1% -$50.3K
WSC icon
84
WillScot Mobile Mini Holdings
WSC
$4.17B
$3.99M 0.55%
85,825
-675
-0.8% -$31.4K
SMAR
85
DELISTED
Smartsheet Inc.
SMAR
$3.83M 0.53%
99,353
-88,694
-47% -$3.87M
BROS icon
86
Dutch Bros
BROS
$8.93B
$3.8M 0.52%
+115,013
New +$3.39M
ITCI
87
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$3.77M 0.52%
54,454
-596
-1% -$41K
ADPT icon
88
Adaptive Biotechnologies
ADPT
$3.89B
$3.54M 0.49%
1,103,441
+392,334
+55% +$1.52M
DNLI icon
89
Denali Therapeutics
DNLI
$4.04B
$3.54M 0.49%
172,331
-1,888
-1% -$35.5K
ROIV icon
90
Roivant Sciences
ROIV
$26.2B
$3.46M 0.48%
328,182
-3,085
-0.9% -$33.3K
NMRA icon
91
Neumora Therapeutics
NMRA
$317M
$3.43M 0.47%
+249,336
New +$4.03M
SIBN icon
92
SI-BONE Inc
SIBN
$852M
$3.41M 0.47%
208,584
-1,743
-0.8% -$32.8K
WNS
93
DELISTED
WNS Holdings
WNS
$3.28M 0.45%
64,825
-59,204
-48% -$3.57M
ALAB icon
94
Astera Labs
ALAB
$56B
$2.18M 0.3%
+29,397
New +$2.18M
CDLX icon
95
Cardlytics
CDLX
$24.7M
$1.93M 0.27%
+13,319
New +$1.12M
LNTH icon
96
Lantheus
LNTH
$6.57B
$1.9M 0.26%
+30,498
New +$1.79M
AEHR icon
97
Aehr Test Systems
AEHR
$4.02B
$1.48M 0.2%
+119,564
New +$1.99M
PRTA icon
98
Prothena Corp
PRTA
$475M
$1.41M 0.19%
57,020
+191
+0.3% +$5.68K
MSCI icon
99
MSCI
MSCI
$40.9B
$1.24M 0.17%
2,219
+31
+1% +$17.4K
TW icon
100
Tradeweb Markets
TW
$21.9B
$1.06M 0.15%
10,140
+142
+1% +$14.3K

Similar funds

Pier Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Pier Capital held 132 positions worth $727M, up 3.9% from $699M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Pier Capital's Q1 2024 filing shows 15 new, 61 increased, 38 reduced and 6 closed positions. Its largest new stake was Camtek: 113,069 shares worth $9.47M. The largest sale was RayzeBio, Inc. Common Stock, an estimated $12.2M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.

  • Pier Capital's largest Q1 2024 buy was Camtek: 113,069 shares worth $9.47M.
  • Pier Capital added most to Q2 Holdings in Q1 2024, an estimated $4.69M increase.
  • Pier Capital's biggest Q1 2024 reduction was Goosehead Insurance, cutting an estimated $9.83M.
  • Pier Capital fully exited RayzeBio, Inc. Common Stock in Q1 2024, selling an estimated $12.2M.
  • Pier Capital's ten largest holdings make up 17% of its $727M portfolio in Q1 2024.
  • Pier Capital opened 15 new positions and closed 6 in Q1 2024.
  • Pier Capital's portfolio value rose 3.9% quarter-over-quarter to $727M.

Based on Pier Capital's 13F filing for Q1 2024, filed 3 May 2024.